Health Condition 1: G978- Other intraoperative and postprocedural complications and disorders of nervous system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients aged 18-65 years belonging to either sex, requiring stellate ganglion block for treatment of clinical cerebral vasospasm after undergoing microsurgical clipping of cerebral aneurysm will be studied.
Exclusion criteria
Exclusion criteria: Refusal of consent, patients with multiple aneurysms and having an unsecured aneurysm, history of allergy to local anaesthetics, disturbed coagulation profile and patient with preexisting pupillary changes where assessment of effectiveness of stellate ganglion block (SGB) would be difficult.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effects of stellate ganglion block (SGB) used for treatment of cerebral vasospasm following acute aneurysmal subarachnoid haemorrhage (aSAH) on cardiac rhythm with Holter monitoring.Timepoint: 24 hours after stellate ganglion block | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To study hemodynamic parameters after stellate ganglion block (SGB) for treatment of cerebral vasospasm following acute aneurysmal subarachnoid haemorrhage (aSAH). 2.To study neurological outcome after treatment of cerebral vasospasm with stellate ganglion block (SGB) following acute aneurysmal subarachnoid haemorrhage (aSAH). Timepoint: Hemodynamic parameters will be recorded 1 hourly. Neurological outcome will be assessed after 3 months. | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi